A two‐year follow‐up of oral antioxidant supplementation in primary open‐angle glaucoma: an open‐label, randomized, controlled trial

Abstract

Oral antioxidant supplementation with or without ω-3 fatty acids does not appear useful as an adjuvant treatment of mild/moderate POAG in the short term.